Notably, BACH1 also functions as a tumor suppressor and controls growth and survival of AML cells by regulating HO-1 expression, suggesting that functional upregulation of BACH1 is a potential strategy for antileukemic therapy [43]. This evidence concerns the gene HMOX1 and neoplasm.